Search

Author/Creator Jensen, Niels Viggo

1. A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1. (4th May 2018)

Authors:
Donskov, Frede; Jensen, Niels Viggo; Smidt-Hansen, Torben; Brøndum, Line; Geertsen, Poul
Journal:
Acta oncologica
Issue:
Volume 57:Number 5(2018)
Page Start:
589
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. Issue 12 (December 2020)

Authors:
Powles, Thomas; van der Heijden, Michiel S; Castellano, Daniel; Galsky, Matthew D; Loriot, Yohann; Petrylak, Daniel P; Ogawa, Osamu; Park, Se Hoon; Lee, Jae-Lyun; De Giorgi, Ugo; Bögemann, Martin; Bamias, Aristotelis; Eigl, Bernhard J; Gurney, Howard; Mukherjee, Som D; Fradet, Yves; Skoneczna, Iw...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 12(2020)
Page Start:
1574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma. Issue 9 (20th March 2021)

Authors:
McDermott, David F.; Lee, Jae-Lyun; Bjarnason, Georg A.; Larkin, James M. G.; Gafanov, Rustem A.; Kochenderfer, Mark D.; Jensen, Niels Viggo; Donskov, Frede; Malik, Jahangeer; Poprach, Alexandr; Tykodi, Scott S.; Alonso-Gordoa, Teresa; Cho, Daniel C.; Geertsen, Poul F.; Climent Duran, Miguel Ange...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 9(2021)
Page Start:
1020
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma. (February 2020)

Authors:
Donskov, Frede; Motzer, Robert J.; Voog, Eric; Hovey, Elizabeth; Grüllich, Carsten; Nott, Louise M.; Cuff, Katharine; Gil, Thierry; Jensen, Niels Viggo; Chevreau, Christine; Negrier, Sylvie; Depenbusch, Reinhard; Bergmann, Lothar; Cornelio, Izzy; Champsaur, Anne; Escudier, Bernard; Pal, Sumanta; ...
Journal:
European journal of cancer
Issue:
Volume 126(2020)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Vinflunine/gemcitabine versus carboplatin/gemcitabine as first-line treatment in cisplatin-ineligible patients with advanced urothelial carcinoma: A randomised phase II trial (VINGEM). (March 2020)

Authors:
Holmsten, Karin; Jensen, Niels Viggo; Mouritsen, Lene Sonne; Jonsson, Erika; Mellnert, Camilla; Agerbæk, Mads; Nilsson, Cecilia; Moe, Mette; Carus, Andreas; Öfverholm, Elisabeth; Lahdenperä, Outi; Brandberg, Yvonne; Johansson, Hemming; Hellström, Mats; Maase, Hans von der; Pappot, Helle; Ullén, A...
Journal:
European journal of cancer
Issue:
Volume 127(2020)
Page Start:
173
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗